CORRELATION OF INFLAMMATION BIOMARKERS WITH THE TRADITIONAL RISK FACTORS IN PATIENTS WITH ACUTE CORONARY SYNDROME

CORRELATION OF INFLAMMATION BIOMARKERS WITH THE TRADITIONAL RISK FACTORS IN PATIENTS WITH ACUTE CORONARY SYNDROME

Actuality of cardiovascular diseases today determines the high interest to study pathogenesis of atherosclerosis and to searching new risk factors which could help to optimize primary and secondary prevention. Study the correlation between biomarkers of inflammation and traditional risk factors (TRF...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. S. Skopec, N. N. Vezikova, I. M. Marusenko, O. Yu. Barysheva, A. V. Malafeev, A. N. Malygin
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-05-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	biomarkers of inflammation traditional risk factors acute coronary syndrome endothelial dysfunction
Online Access:	https://www.rpcardio.online/jour/article/view/1233
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Significance of inflammation markers in patients with coronary microvascular dysfunction and non-obstructive coronary artery disease
by: K. V. Kop’eva, et al.
Published: (2023-07-01)

Novel Biomarkers of Endothelial Dysfunction in Cardiovascular Diseases
by: Z. M. Abdurakhmanov, et al.
Published: (2021-09-01)

THE INFLUENCE OF CORONARY BYPASS ON ENDOTHELIAL AND ERECTILE DYSFUNCTION IN ISCHEMIC HEART DISEASE
by: S. A. Pomeshkina, et al.
Published: (2015-01-01)

Endothelial dysfunction and prognosis after coronary interventions in patients with coronary heart disease and arterial hypertension
by: M. V. Kazak, et al.
Published: (2011-10-01)

Low-grade systemic inflammation in patients with long COVID: The role of imbalance of endotoxin-releasing systems and vasoconstrictor markers
by: V. A. Beloglazov, et al.
Published: (2024-09-01)

CARDIOVASCULAR RISK IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE ROLE OF SYSTEMIC INFLAMMATION AND ENDOTHELIAL DYSFUNCTION
by: D. A. Poddubnyy, et al.
Published: (2016-01-01)

Importance of biological markers in the assessment of endothelial dysfunction
by: Yu. S. Timofeev, et al.
Published: (2024-10-01)

The role of markers of endothelial dysfunction in the pathogenesis of coronary microvascular dysfunction in patients with non-obstructive coronary artery disease
by: K. V. Kopeva, et al.
Published: (2024-10-01)

PROGNOSTIC BLOCK-SCHEME OF CLINICAL OUTCOME OF ACUTE CORONARY SYNDROME INTO Q-MYOCARDIAL INFARCTION. PART I
by: M. G. Alieva, et al.
Published: (2015-03-01)

Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register
by: I. S. Skopets, et al.
Published: (2020-11-01)

Preliminary assessment of serum endocan as a biomarker of disease severity in Plasmodium falciparum and Plasmodium vivax malaria
by: Kwannan Nantavisai, et al.
Published: (2025-07-01)

ASSESSMENT OF SYSTEMIC INFLAMMATORY REACTION IN ACUTE MYOCARDIAL INFARCTION: STATUS UPDATE ON THE PROBLEM
by: M. A Kachkovsky, et al.
Published: (2015-09-01)

Clinical Profile of Patients with Ischaemic Heart Disease and its Correlation with Rheumatoid Factor: A Cross-sectional Study
by: Sachin Shivnitwar, et al.
Published: (2025-07-01)

Prediction of coronary atherosclerosis in young patients with coronary artery disease using a non-invasive biomarker
by: V. E. Oleinikov, et al.
Published: (2020-12-01)

Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis
by: M. V. Klimushina, et al.
Published: (2016-11-01)

GRAPHICAL REPRESENTATION OF THE CLINICAL OUTCOME OF ACUTE CORONARY SYNDROME INTO EFFORT ANGINA OF III FUNCTIONAL CLASS AT THE HOSPITAL LEVEL (PART II)
by: Marzhanat G. Alieva
Published: (2017-10-01)

Construction of Immune-Related circRNA-miRNA-mRNA Network and Identification of circRNAs as Biomarkers in Coronary Atherosclerotic Heart Disease
by: Haiyan Qian, et al.
Published: (2024-11-01)

Inflammation, Immunity, and Hypertension
by: Arisya Agita, et al.
Published: (2017-08-01)

BLOOD LIPID AND NON-LIPID BIOMARKERS IN NOVOSIBIRSK MEN WITH CORONARY ATHEROSCLEROSIS
by: Yu. I. Ragino, et al.
Published: (2009-04-01)

Assessment of Coronary Artery Disease in Non-Valvular Atrial Fibrillation: Is This Light at the End of the Tunnel?
by: Batta A, et al.
Published: (2024-11-01)

OSTEONECTIN AND SELECTED BIOMARKERS IN ATHEROSCLEROTIC OCCLUSION AND CALCINOSIS OF CORONARY ARTERIES
by: Yu. I. Ragino, et al.
Published: (2010-08-01)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023-01-01)

Biomarkers of hemodynamic status in patients with moderate and severe COVID-19
by: Yu. K. Shapovalov
Published: (2022-12-01)

Arterial endothelial dysfunction and its role for prognosis assessment in cardiovascular patients
by: G. N. Soboleva, et al.
Published: (2010-04-01)

Multi‐omics analysis revealed biomarkers for coronary atherosclerosis: Occurrence and development
by: Mengxue He, et al.
Published: (2025-08-01)

Lipid and pleiotropic effects of atorvastatin in patients with acute coronary syndrome
by: A. A. Yalymov, et al.
Published: (1970-01-01)

Significance of assessing the inflammatory markers of vascular wall activation in age-related macular degeneration
by: N. V. Balatskaya, et al.
Published: (2025-07-01)

CLINICAL SIGNIFICANCE OF ENDOTHELIAL DYSFUNCTION IN NON-ST-SEGMENT-ELEVATION ACUTE CORONARY SYNDROME IN SUBJECTS UNDER 55 YEARS OF AGE
by: M. G. Omelyanenko, et al.
Published: (2003-08-01)

ENDOTHELIAL DYSFUNCTION – A KEY FACTOR IN ATHEROSCLEROSIS PATHOGENESIS
by: E. N. Vorobyeva, et al.
Published: (2010-04-01)

EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY
by: V. V. Yakusevich, et al.
Published: (2015-09-01)

Gluconeogenesis related gene signatures as biomarkers for nonspecific orbital inflammation
by: Bahe Dong, et al.
Published: (2025-07-01)

Bone morphogenetic protein 10 serves as a biomarker and a potential therapeutic target for endothelial dysfunction in endotoxin-induced acute lung injury
by: Wen-Kuang Yu, et al.
Published: (2025-07-01)

Quality of life in patients with coronary heart disease: interrelation with components of metabolic syndrome and markers of systemic inflammation
by: I. D. Bespalova, et al.
Published: (2012-12-01)

Role of lipopolysaccharide in genesis of microvascular complications in type 1 diabetes mellitus
by: V. A. Beloglazov, et al.
Published: (2024-11-01)

Erectile dysfunction and cardiovascular disease: old problem, new approaches
by: S. I. Gamidov, et al.
Published: (2006-12-01)

Dysfunction of vascular endothelium at arterial hypertension and coronary disease (literature review)
by: L. B. Koryakina, et al.
Published: (2013-04-01)

Endothelial dysfunction role in atherosclerosis pathogenesis
by: E. N. Vorobyeva, et al.
Published: (2006-12-01)

The role of systemic inflammation in the pathogenesis of hyperkinetic disorder
by: Rauf F. Gasanov, et al.
Published: (2024-04-01)

SECONDARY MITOCHONDRIAL DYSFUNCTION IN ACUTE CORONARY SYNDROME
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

Advanced Lung Cancer Inflammation Index as a Predictor of Coronary Slow Flow Phenomenon in Patients with Angina and Non-Obstructive Coronary Arteries
by: Jiang YT, et al.
Published: (2025-05-01)